Gary W. Pace, Director at Cardiff Oncology, Inc. (CRDF), bought 10,000 shares at $10.20 ($102K) on 2021-03-23, disclosed to the SEC on 2021-03-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.20 | 5,000 | $51K | 49.9% |
| 2 | $10.21 | 2,500 | $26K | 25.0% |
| 3 | $10.31 | 2,500 | $26K | 25.2% |
| Total | $10.23 avg | 10,000 | $102K | 100% |
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| CRDF | BUY | 2024-12-12 | $940K | — | Filing → |
| PCRX | SELL | 2024-03-08 | $4.5M | — | Filing → |